Sunshine Pharma: ABA001 Injection Clinical Trial Application Approved

Sunshine Nuohe Announcement: Recently, the company and its wholly-owned subsidiary, Beijing Arna Technology Co., Ltd., received the "Notice of Approval for Drug Clinical Trial" issued by the National Medical Products Administration. The company's clinical trial application for the investigational product ABA001 injection has been approved. This drug is a class 1 innovative drug, intended for the indication of hypertension.